Wie ist das Verhältnis von 2070 zu PS im Vergleich zu anderen Unternehmen?

2070 is good value based on its Price-To-Sales Ratio (2.5x) compared to the peer average (5.2x).

Wie ist das Verhältnis von 2070 zu PS im Vergleich zu anderen Unternehmen der Branche Asian Pharmaceuticals?

2070 is good value based on its Price-To-Sales Ratio (2.5x) compared to the Asian Pharmaceuticals industry average (2.8x).

Wie hoch ist das PS Verhältnis von 2070 im Vergleich zu seinem fairen PS Verhältnis? Dies ist das erwartete PS Verhältnis unter Berücksichtigung des prognostizierten Gewinnwachstums des Unternehmens, der Gewinnspannen und anderer Risikofaktoren.

2070 is good value based on its Price-To-Sales Ratio (2.5x) compared to the estimated Fair Price-To-Sales Ratio (4.4x).

Wie hoch ist der faire Preis von 2070, wenn man die zukünftigen Cashflows betrachtet? Für diese Schätzung verwenden wir ein Discounted-Cashflow-Modell.

2070 (SAR32.65) is trading below our estimate of [[fair value]] (SAR41.63)

Wie sieht die 12-Monats-Prognose der Analysten aus und haben wir statistisches Vertrauen in das Konsenskursziel?

Target price is less than 20% higher than the current share price.

Saudi Pharmaceutical Industries and Medical Appliances (SASE:2070) - Aktienkurs, Nachrichten und Analyse

2070 Aktienübersicht

Die Saudi Pharmaceutical Industries and Medical Appliances Corporation entwickelt, produziert und vertreibt medizinische und pharmazeutische Produkte im Königreich Saudi-Arabien.

Über das Unternehmen

2070 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	5/6
Künftiges Wachstum	4/6
Vergangene Leistung	0/6
Finanzielle Gesundheit	2/6
Dividenden	0/6

Belohnungen

Trading at 21.6% below our estimate of its fair value

Earnings are forecast to grow 38.83% per year

Earnings have grown 27.8% per year over the past 5 years

Trading at good value compared to peers and industry

Risikoanalyse

Interest payments are not well covered by earnings

Saudi Pharmaceutical Industries and Medical Appliances Corporation Wettbewerber

Middle East Pharmaceutical Industries

SASE:4016

ر.س2.7b

Jamjoom Pharmaceuticals Factory

SASE:4015

ر.س11.6b

Kissei Pharmaceutical

TSE:4547

JP¥165.8b

Beijing Foyou PharmaLTD

SHSE:601089

CN¥7.3b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Saudi Pharmaceutical Industries and Medical Appliances
Historische Aktienkurse
Aktueller Aktienkurs	ر.س32.70
52-Wochen-Hoch	ر.س42.85
52-Wochen-Tief	ر.س24.92
Beta	0.59
11 Monat Veränderung	-2.68%
3 Monate Veränderung	20.22%
1 Jahr Veränderung	7.57%
33 Jahre Veränderung	-16.15%
5 Jahre Veränderung	25.77%
Veränderung seit IPO	20.80%

Aktuelle Nachrichten und Updates

Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Sep 05

Recent updates

Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Sep 05

Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Mar 21

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Jun 26

Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Mar 14

Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Aug 02

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

May 19

One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

May 12

A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Feb 20

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 18

Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Mar 30

Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

Feb 23

What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Jan 19

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

Dec 16

Aktionärsrenditen

	2070	SA Pharmaceuticals	SA Markt
7D	-1.1%	0.03%	0.1%
1Y	7.6%	13.8%	-9.5%

Rendite im Vergleich zur Industrie: 2070 underperformed the SA Pharmaceuticals industry which returned 13.8% over the past year.

Rendite vs. Markt: 2070 exceeded the SA Market which returned -9.5% over the past year.

Preisvolatilität

Is 2070's price volatile compared to industry and market?
2070 volatility
2070 Average Weekly Movement	5.1%
Pharmaceuticals Industry Average Movement	6.5%
Market Average Movement	4.7%
10% most volatile stocks in SA Market	7.4%
10% least volatile stocks in SA Market	2.9%

Stabiler Aktienkurs: 2070 has not had significant price volatility in the past 3 months compared to the SA market.

Volatilität im Zeitverlauf: 2070's weekly volatility (5%) has been stable over the past year.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1986	n/a	Jerome Roger Cabannes	www.spimaco.com.sa

Die Saudi Pharmaceutical Industries and Medical Appliances Corporation entwickelt, produziert und vertreibt medizinische und pharmazeutische Produkte im Königreich Saudi-Arabien. Das Unternehmen stellt außerdem chemische Grundstoffe und Produkte, Humanarzneimittel, einschließlich Kosmetika, her und ist im Groß- und Einzelhandel mit Arzneimitteln und verwandten Produkten tätig. Es betreibt und unterhält Gesundheitseinrichtungen.

Saudi Pharmaceutical Industries and Medical Appliances Corporation's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Saudi Pharmaceutical Industries and Medical Appliances im Vergleich zum Marktanteil des Unternehmens?
2070 grundlegende Statistiken
Marktanteil	ر.س3.92b
Gewinn(TTM)	-ر.س17.58m
Umsatz(TTM)	ر.س1.56b

2.5x

Kurs-Umsatz-Verhältnis

-223.2x

Kurs-Gewinn-Verhältnis

Ist 2070 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
2070 Gewinn- und Verlustrechnung (TTM)
Einnahmen	ر.س1.56b
Kosten der Einnahmen	ر.س878.96m
Bruttogewinn	ر.س683.07m
Sonstige Ausgaben	ر.س700.65m
Umsatz	-ر.س17.58m

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-0.15
Bruttomarge	43.73%
Nettogewinnspanne	-1.13%
Schulden/Eigenkapital-Verhältnis	91.0%

Wie hat sich 2070 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

2070 Aktienübersicht

Belohnungen

Risikoanalyse

Saudi Pharmaceutical Industries and Medical Appliances Corporation Wettbewerber

SASE:4016

ر.س2.7b

SASE:4015

ر.س11.6b

TSE:4547

JP¥165.8b

SHSE:601089

CN¥7.3b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Now 21% undervalued

Now 22% undervalued

Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Second quarter 2024 earnings released: EPS: ر.س0.28 (vs ر.س0.19 in 2Q 2023)

Price target decreased by 9.5% to ر.س33.33

First quarter 2024 earnings released: EPS: ر.س0.30 (vs ر.س0.46 in 1Q 2023)

Recent updates

Now 21% undervalued

Now 22% undervalued

Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Second quarter 2024 earnings released: EPS: ر.س0.28 (vs ر.س0.19 in 2Q 2023)

Price target decreased by 9.5% to ر.س33.33

First quarter 2024 earnings released: EPS: ر.س0.30 (vs ر.س0.46 in 1Q 2023)

Saudi Pharmaceutical Industries and Medical Appliances Corporation, Annual General Meeting, Jun 02, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Saudi Pharmaceutical Industries and Medical Appliances Corporation Appoints Jerome Cabannes as Chief Executive Officer

Saudi Pharmaceutical Industries and Medical Appliances Corporation (SASE:2070) acquired 15% stake in Dammam Pharmaceutical from Cooper Pharma for SAR 27 million.

Third quarter 2023 earnings released: ر.س0.32 loss per share (vs ر.س0.38 loss in 3Q 2022)

Now 25% undervalued

Price target increased by 40% to ر.س37.83

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

First quarter 2023 earnings released: EPS: ر.س0.47 (vs ر.س0.29 in 1Q 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Now 23% undervalued

Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Less than half of directors are independent

Third quarter 2022 earnings released: ر.س0.38 loss per share (vs ر.س0.062 profit in 3Q 2021)

Saudi Pharmaceutical Industries and Medical Appliances Corporation(SASE:2070) dropped from FTSE All-World Index (USD)

Second quarter 2022 earnings released: ر.س0.43 loss per share (vs ر.س0.26 profit in 2Q 2021)

Consensus EPS estimates fall by 39%

Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Price target decreased to ر.س34.50

Saudi Pharmaceutical Industries and Medical Appliances Corporation Approves Cash Dividend, Payable on June 27, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

Saudi Pharmaceutical Industries and Medical Appliances Corporation, Annual General Meeting, Jun 08, 2022

One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

Price target increased to ر.س36.25

Less than half of directors are independent

Saudi Pharmaceutical Industries and Medical Appliances Corporation Announces Executive Changes

Full year 2021 earnings: EPS and revenues miss analyst expectations

Saudi Pharmaceutical Industries and Medical Appliances Corporation Approves Formation of the Audit Committee

A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Saudi Pharmaceutical Industries and Medical Appliances Corporation, Annual General Meeting, Feb 23, 2022

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Third quarter 2021 earnings released: EPS ر.س0.06 (vs ر.س0.56 in 3Q 2020)

Second quarter 2021 earnings released: EPS ر.س0.24 (vs ر.س0.21 in 2Q 2020)

Investor sentiment improved over the past week

Upcoming dividend of ر.س1.00 per share

First quarter 2021 earnings released: EPS ر.س0.22 (vs ر.س0.38 in 1Q 2020)

Saudi Pharmaceutical Industries and Medical Appliances Corporation Proposes Dividend for the Year Ended December 31, 2020

Full year 2020 earnings released: EPS ر.س0.91 (vs ر.س3.63 loss in FY 2019)

Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

New 90-day high: ر.س38.65

Third quarter 2020 earnings released: EPS ر.س0.52

An unknown buyer acquired a part of an equity portfolio of Saudi Pharmaceutical Industries and Medical Appliances Corp for approximately SAR 480 million.

New 90-day high - ر.س36.95

New 90-day high - ر.س32.50

Earnings released

Aktionärsrenditen

Preisvolatilität

Über das Unternehmen

Erträge & Einnahmen